The Latest Breaking News from FDA

Mifepristone, legal in the US for more than 20 years, is now under threat.

In the latest effort to limit abortion access, opponents of the procedure are seeking to ban one of the two drugs used in medication abortions

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name

Demand for abortion pills has soared since the Supreme Court decided to overturn Roe v. Wade.

CBD has shown remarkable efficacy in treating seizure disorders. Now we know why this might be.

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

Apellis Pharmaceuticals snagged FDA approval for the first-ever geographic atrophy treatment, leading APLS stock to surge Tuesday.